Monographie - Epirubicin hydrochloride

Son güncelleme :
19/11/2024

Epirubicin hydrochloride

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine	Malezya
Axirubicine	Almanya
Bendaepi	Almanya
Binarin	Meksika
Bioepycina	Polonya
Crisabon	Arjantin
Cuatroepi	Arjantin
Ecclepia	Romanya
Elebicin	Meksika
Ellence	Amerika Birleşik Devletleri
Epi Cell	Almanya
Epidoxo	Arjantin, Şili, Venezuela
Epifil	Ekvador
Epilem	Kolombiya, Meksika
Epimedac	Almanya
Epirubicin	Avustralya, Avusturya, Belçika, Büyük Britanya, Danimarka, İsveç, İsviçre, İzlanda, Macaristan, Suudi Arabistan, Türkiye, yeni Zelanda
Epirubicina	Arjantin, Ekvador, İspanya, Kolombiya, Meksika, Romanya
Epirubicine	Belçika, Fransa, İsviçre
Farmarubicin	Türkiye
Farmorubicin	Avusturya, Brezilya, Danimarka, Finlandiya, İsveç, İsviçre, Norveç, Suudi Arabistan, Yunanistan
Farmorubicin CSV	Güney Afrika Cumhuriyeti
Farmorubicin PFS	Hırvatistan, Polonya, Slovenya
Farmorubicin RD	Brezilya, İsviçre, Polonya, rusça
Farmorubicin RTU	Hollanda
Farmorubicina	Brezilya, İspanya, İtalya, Portekiz
Farmorubicine	Belçika, Fransa
Pharmorubicin	Büyük Britanya

Kaynaklar : Epirubicin hydrochloride

	tip	yayın
148	Dergi	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Dergi	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Dergi	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Dergi	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Dergi	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Dergi	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Dergi	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Dergi	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Dergi	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Dergi	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Dergi	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Dergi	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Dergi	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Laboratuar	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Dergi	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Laboratuar	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Laboratuar	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Dergi	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	afiş	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Dergi	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Dergi	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales